Credit Suisse Group reiterated coverage on Galecto with a new price target

3/16/21 8:17:33 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Credit Suisse Group reiterated coverage of Galecto with a rating of Outperform and set a new price target of $12.00 from $29.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$GLTO

Date	Price Target	Rating	Analyst
8/6/2021	$12.00 → $7.00	Outperform	Credit Suisse